UBS Group Issues Pessimistic Forecast for ZimVie (NASDAQ:ZIMV) Stock Price

ZimVie (NASDAQ:ZIMV) had its price target cut by UBS Group from $16.00 to $10.00 in a research note released on Thursday morning,Benzinga reports. They currently have a neutral rating on the stock.

A number of other equities analysts also recently weighed in on ZIMV. Needham & Company LLC restated a “hold” rating on shares of ZimVie in a report on Wednesday, April 9th. B. Riley assumed coverage on shares of ZimVie in a research report on Thursday, April 10th. They issued a “buy” rating and a $16.00 price objective for the company.

ZimVie Stock Down 0.3%

ZIMV stock opened at $8.69 on Thursday. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.94 and a quick ratio of 1.38. The stock has a market capitalization of $241.99 million, a P/E ratio of -0.66 and a beta of 2.16. ZimVie has a fifty-two week low of $8.56 and a fifty-two week high of $22.40. The business has a 50-day moving average of $10.02 and a 200-day moving average of $12.51.

ZimVie (NASDAQ:ZIMV) last released its earnings results on Thursday, May 8th. The company reported $0.27 earnings per share for the quarter, beating analysts’ consensus estimates of $0.21 by $0.06. ZimVie had a negative net margin of 77.31% and a positive return on equity of 2.90%. The business had revenue of $112.00 million during the quarter, compared to the consensus estimate of $113.10 million. On average, sell-side analysts anticipate that ZimVie will post 0.6 earnings per share for the current fiscal year.

Hedge Funds Weigh In On ZimVie

Large investors have recently made changes to their positions in the company. Barclays PLC increased its position in ZimVie by 338.4% during the 3rd quarter. Barclays PLC now owns 43,437 shares of the company’s stock worth $690,000 after buying an additional 33,529 shares during the period. JPMorgan Chase & Co. boosted its holdings in ZimVie by 66.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 183,419 shares of the company’s stock valued at $2,911,000 after purchasing an additional 73,395 shares during the period. Principal Financial Group Inc. increased its holdings in shares of ZimVie by 9.8% during the fourth quarter. Principal Financial Group Inc. now owns 19,054 shares of the company’s stock worth $266,000 after purchasing an additional 1,702 shares during the period. Bank of New York Mellon Corp raised its position in shares of ZimVie by 0.9% in the fourth quarter. Bank of New York Mellon Corp now owns 100,638 shares of the company’s stock valued at $1,404,000 after buying an additional 943 shares in the last quarter. Finally, LPL Financial LLC acquired a new stake in ZimVie during the fourth quarter worth approximately $993,000. Institutional investors own 95.63% of the company’s stock.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.